MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202611081083 A) filed by Noida Institute Of Engineering And Technology Niet on July 01, 2026, for Glycan-Engineered Vesicle System For Dual Delivery Of Doxorubicin And Sorafenib In Liver Cancer.
Inventors include Abhijit Debnath; and Shruti Varshney.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention discloses a glycan-functionalized bacterial outer membrane vesicle nanosystem designated HA-Man-OMVs@DOX/SOR for synergistic chemo- immunotherapy of hepatocellular carcinoma. The nanosystem comprises outer membrane vesicles isolated from Escherichia coli, surface-engineered with DSPE...